August 16, 2019

CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device

BAROSTIM™ NEO provides significant clinical benefit to heart failure patients. MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ — CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from … Continued